Leishmania panamensis transmission in the domestic environment: the results of a prospective epidemiological survey in Santander, Colombia
- PMID: 17361849
Leishmania panamensis transmission in the domestic environment: the results of a prospective epidemiological survey in Santander, Colombia
Abstract
Introduction: Domestic transmission now appears to be the principal route of Leishmania panamensis infection in deforested regions characterized by the replacement of primary forest by permanent plantations, i,e coffee or cacao crops. This paper presents the results of the disease patterns in a representative population of the Opón focus, in Santander, Colombia.
Objective: The principal aims were: 1) to measure the incidence rate in a representative population of the Opón focus; 2) to identify demographic risk factors for infection; 3) to estimate the proportion of infections which cause disease; 4) to estimate the protection against disease from acquired immunity; 5) to estimate the frequency of reactivations, and 6) to estimate the risk of mucosal leishmaniasis.
Material and methods: A 19 month prospective survey of leishmaniasis caused by Leishmania panamensis was carried out amongst 1380 people in a cacao growing region of Santander Department, Colombia. The population was diagnosed clinically and by the Montenegro skin test (at two time points).
Results: The incidence rate was 0.19 infections/person-year, with 31% of infections apparently subclinical. The risk of acquiring cutaneous leishmaniasis decreased with age even in the absence of apparent previous infections. Protective immunity followed both clinical and subclinical infections, persisting for at least 10 years after a primary lesion. Mucocutaneous leishmaniasis was detected in 12% of the population with cutaneous lesions, of which 77% had mild symptoms, and 23% perforated nasal septa. The risk of mucosal leishmaniasis was greatest for males, and for people whose primary cutaneous lesion was on the head.
Conclusion: The average age of infection in Opón, 7.7 years (1/lambda), and the absence of gender as a risk factor is highly indicative of intradomiciliary or peridomiciliary transmission.
Similar articles
-
[Presence of infected vectors of Leishmania (V.) panamensis within dwellings in two endemic foci in the foothill of the middle Magdalena valley, western Boyacá, Colombia].Biomedica. 2006 Oct;26 Suppl 1:82-94. Biomedica. 2006. PMID: 17361845 Spanish.
-
Cutaneous leishmaniasis imported from Colombia to Northcentral Venezuela: implications for travel advice.Travel Med Infect Dis. 2008 Nov;6(6):376-9. doi: 10.1016/j.tmaid.2008.06.012. Epub 2008 Sep 5. Travel Med Infect Dis. 2008. PMID: 18984484
-
Mucosal leishmaniasis due to Leishmania (Viannia) panamensis in Colombia: clinical characteristics.Am J Trop Med Hyg. 1998 Jul;59(1):49-52. doi: 10.4269/ajtmh.1998.59.49. Am J Trop Med Hyg. 1998. PMID: 9684627
-
The epidemiology and control of leishmaniasis in Andean countries.Cad Saude Publica. 2000 Oct-Dec;16(4):925-50. doi: 10.1590/s0102-311x2000000400013. Cad Saude Publica. 2000. PMID: 11175518 Review.
-
Clinical use of polymerase chain reaction performed on peripheral blood and bone marrow samples for the diagnosis and monitoring of visceral leishmaniasis in HIV-infected and HIV-uninfected patients: a single-center, 8-year experience in Italy and review of the literature.Clin Infect Dis. 2007 Jun 15;44(12):1602-10. doi: 10.1086/518167. Epub 2007 May 7. Clin Infect Dis. 2007. PMID: 17516404 Review.
Cited by
-
Sex bias in infectious disease epidemiology: patterns and processes.PLoS One. 2013 Apr 24;8(4):e62390. doi: 10.1371/journal.pone.0062390. Print 2013. PLoS One. 2013. PMID: 23638062 Free PMC article.
-
Double blind, randomized controlled trial, to evaluate the effectiveness of a controlled nitric oxide releasing patch versus meglumine antimoniate in the treatment of cutaneous leishmaniasis [NCT00317629].Trials. 2006 May 15;7:14. doi: 10.1186/1745-6215-7-14. Trials. 2006. PMID: 16700912 Free PMC article.
-
Use of GnRH Agonist in Dogs Affected with Leishmaniosis.Animals (Basel). 2021 Feb 7;11(2):432. doi: 10.3390/ani11020432. Animals (Basel). 2021. PMID: 33562362 Free PMC article.
-
Risk factors for cutaneous leishmaniasis in a high-altitude forest region of Peru.Trop Med Health. 2021 May 17;49(1):40. doi: 10.1186/s41182-021-00332-0. Trop Med Health. 2021. PMID: 34001266 Free PMC article.
-
Cost-effectiveness of meglumine antimoniate versus miltefosine caregiver DOT for the treatment of pediatric cutaneous leishmaniasis.PLoS Negl Trop Dis. 2017 Apr 6;11(4):e0005459. doi: 10.1371/journal.pntd.0005459. eCollection 2017 Apr. PLoS Negl Trop Dis. 2017. PMID: 28384261 Free PMC article.